The companies inked a five-year agreement that will see CVS Health’s Caremark PBM managing such services as claims processing and prescription fulfillment services for IngenioRx.
Allergan said that the decision was not the end of the road for their intellectual property protection efforts around Restasis.
The merger will bring the two companies together to create the fifth-largest generics business in the United States.
For the second year at the NCPA Annual Conference, McKesson RxOwnership took part in the official NCPA student education program with a presentation led by Kim Diemand, VP North Central Region, McKesson RxOwnership.
The awards come as NCPA rolls out its 2017 NCPA Digest, which found that the state of independent community pharmacies continues to grow and expand the scope of services pharmacists can offer their patients.
According to the World Health Organization, roughly one-third of patients diagnosed with plaque psoriasis is younger than 20 years of age, and adolescents in particular have limited treatment options.
The product had branded and generic U.S. sales of approximately $64.9 million for the 12 months ended August 2017, according to QuintilesIMS data.
The companies said the partnership would help improve decision-making abilities for patients and their care teams — including physicians, pharmacists and payers.
The organization has named Amgen chairman and CEO Robert Bradway to the chairman-elect position, effective immediately, and named two more industry executives to the board.
FlavoRx SVP marketing Chad Baker talked to Drug Store News about how the company helps pharmacies make medication more palatable for children and makes it easy for pharmacists to flavor medication by integrating it into existing reconstitution workflow.